higher linoleic acid (Ï‰-6) was associated with reduced risks of low-grade (hr = 0.75, 95% ci = 0.56 to 0.99) and total prostate cancer (hr = 0.77, 95% ci = 0.59 to 1.01); however, there was no dose response.